Clinical trials recruiting in eMkhomazi, South Africa
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 6
Conditions recruiting in eMkhomazi, South Africa
Recruiting trials in eMkhomazi, South Africa
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Common questions
How many clinical trials are recruiting in eMkhomazi, South Africa?
7 recruiting trials have at least one study site in eMkhomazi, South Africa.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.